Myocardial sympathetic innervation in patients with chronic coronary artery disease: Is reduction in coronary flow reserve correlated with sympathetic denervation?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 2, 2007, Pages 206-211

  Fricke, Eva ^a   Fricke, Harald ^a   Eckert, Siegfried ^a   Zijlstra, Sytze ^a   Weise, Reiner ^a   Lindner, Oliver ^a   Horstkotte, Dieter ^a   Burchert, Wolfgang ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Coronary heart disease; Ischaemia; Positron emission tomography; Sympathetic nervous system

Indexed keywords

AMIODARONE; AMMONIA N 13; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUORODEOXYGLUCOSE F 18; HYDROXYEPHEDRINE C 11; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DRUG RETENTION; FEMALE; HEART DENERVATION; HEART INNERVATION; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HEART PERFUSION; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; STATISTICAL SIGNIFICANCE; SYMPATHETIC INNERVATION;

CHRONIC DISEASE; CORONARY ARTERIOSCLEROSIS; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HEART; HUMANS; MALE; MIDDLE AGED; STATISTICS; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM;

EID: 33846409094     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0236-x     Document Type: Article

References (31)

1. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151-8.
2. 18F-FDG PET. J Nucl Med 2001;42:1166-73.
3. Di Carli MF, Maddahi J, Rokhsar S, Schelbert HR, Bianco-Batlles D, Brunken RC, et al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg 1998;116:997-1004.
4. vom Dahl J, Altehoefer C, Buchin P, Sheehan FH, Schwarz ER, Koch KC, et al. Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a followup study of 161 patients with coronary heart disease [in German]. Z Kardiol 1996;85:868-81.
5. Zipes DP. Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation 1990;82:1095-105.
6. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998;98:2334-51.
7. Luisi AJ Jr., Fallavollita JA, Suzuki G, Canty JM Jr. Spatial inhomogeneity of sympathetic nerve function in hibernating myocardium. Circulation 2002;106:779-81.
8. 11C-hydroxyephedrine retention in hibernating myocardium: chronic inhomogeneity of sympathetic innervation in the absence of infarction. J Nucl Med 2005;46:1368-74.
9. Bulow HP, Stahl F, Lauer B, Nekolla SG, Schuler G, Schwaiger M, et al. Alterations of myocardial presynaptic sympathetic innervation in patients with multi-vessel coronary artery disease but without history of myocardial infarction. Nucl Med Commun 2003;24:233-9.
10. Matsunari I, Schricke U, Bengel FM, Haase HU, Barthel P, Schmidt G, et al. Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes. Circulation 2000;101:2579-85.
11. Haas F, Augustin N, Holper K, Wottke M, Haehnel C, Nekolla S, et al. Time course and extent of improvement of dysfunctioning myocardium in patients with coronary artery disease and severely depressed left ventricular function after revascularization: correlation with positron emission tomographic findings. J Am Coll Cardiol 2000;36:1927-34.
12. Abe S, Takeishi Y, Chiba J, Ikeda K, Tomoike H. Comparison of adenosine and treadmill exercise thallium-201 stress tests for the detection of coronary artery disease. Jpn Circ J 1993;57:1111-9.
13. Cuocolo A, Soricelli A, Pace L, Nicolai E, Castelli L, Nappi A, et al. Adenosine technetium-99m-methoxy isobutyl isonitrile myocardial tomography in patients with coronary artery disease: comparison with exercise. J Nucl Med 1994;35:1110-5.
14. Cuocolo A, Nicolai E, Soricelli A, Pace L, Nappi A, Sullo P, et al. Technetium 99m-labeled tetrofosmin myocardial tomography in patients with coronary artery disease: comparison between adenosine and dynamic exercise stress testing. J Nucl Cardiol 1996;3:194-203.
15. Santos-Ocampo CD, Herman SD, Travin MI, Garber CE, Ahlberg AW, Messinger DE, et al. Comparison of exercise, dipyridamole, and adenosine by use of technetium 99m sestamibi tomographic imaging. J Nucl Cardiol 1994;1:57-64.
16. Yoshinaga K, Katoh C, Noriyasu K, Iwado Y, Furuyama H, Ito Y, et al. Reduction of coronary flow reserve in areas with and without ischemia on stress perfusion imaging in patients with coronary artery disease: a study using oxygen 15-labeled water PET. J Nucl Cardiol 2003;10:275-83.
17. Schwaiger M, Kalff V, Rosenspire K, Haka MS, Molina E, Hutchins GD, et al. Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation 1990;82:457-64.
18. Campeau L. Grading of angina pectoris [letter]. Circulation 1976;54:522-3.
19. 11C]Acetate as a quantitative perfusion tracer in myocardial PET. J Nucl Med 2001;42:1174-82.
20. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990;15:1032-42.
21. 13N]ammonia in human and canine blood. J Nucl Med 1990;31:163-7.
22. Port SC, ed. Imaging guidelines for nuclear cardiology procedures, part 2. American Society of Nuclear Cardiology. J Nucl Cardiol 1999;6:G47-84.
23. Dae MW, Herre JM, O'Connell JW, Botvinick EH, Newman D, Munoz L. Scintigraphic assessment of sympathetic innervation after transmural versus nontransmural myocardial infarction. J Am Coll Cardiol 1991;17:1416-23.
24. Hartikainen J, Kuikka J, Mantysaari M, Lansimies E, Pyorala K. Sympathetic reinnervation after acute myocardial infarction. Am J Cardiol 1996;77:5-9.
25. 11C-hydroxyephedrine as marker for neuronal catecholamine retention in reperfused canine myocardium. Coron Artery Dis 1991;2:923-9.
26. Lichtlen PR, Nikutta P, Jost S, Deckers J, Wiese B, Rafflenbeul W. Anatomical progression of coronary artery disease in humans as seen by prospective, repeated, quantitated coronary angiography. Relation to clinical events and risk factors. The INTACT Study Group. Circulation 1992;86:828-38.
27. Anastasiou-Nana MI, Terrovitis JV, Athanasoulis T, Karaloizos L, Geramoutsos A, Pappa L, et al. Prognostic value of iodine-123- metaiodobenzylguanidine myocardial uptake and heart rate variability in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2005;96:427-31.
28. Wakabayashi T, Nakata T, Hashimoto A, Yuda S, Tsuchihashi K, Travin MI. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. J Nucl Med 2001;42:1757-67.
29. Simoes MV, Barthel P, Matsunari I, Nekolla SG, Schomig A, Schwaiger M, et al. Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction. Eur Heart J 2004;25:551-7.
30. Knuuti J, Sipola P. Is it time for cardiac innervation imaging? Q J Nucl Med Mol Imaging 2005;49:97-105.
31. Watanabe T, Yamaki M, Yamauchi S, Minamihaba O, Miyashita T, Kubota I, et al. Regional prolongation of ARI and altered restitution properties cause ventricular arrhythmia in heart failure. Am J Physiol Heart Circ Physiol 2002;282:H212-8.